SIGMA-ALDRICH sigma-aldrich.com Material Safety Data Sheet
1. PRODUCT AND COMPANY IDENTIFICATION
3050 Spruce Street SAINT LOUIS MO 63103 USA
both supplier and manufacturer) Preparation Information
Product Safety - Americas Region 1-800-521-8956
2. HAZARDS IDENTIFICATION Emergency Overview OSHA Hazards Target Organ Effect, Harmful by ingestion., Irritant Target Organs GHS Classification Acute toxicity, Oral (Category 4) Skin irritation (Category 2) Eye irritation (Category 2A) Specific target organ toxicity - single exposure (Category 3) GHS Label elements, including precautionary statements
Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
Do not eat, drink or smoke when using this product.
Use only outdoors or in a well-ventilated area.
Wear protective gloves/ eye protection/ face protection.
IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell.
IF ON SKIN: Wash with plenty of soap and water.
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for
Sigma - D9628
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Call a POISON CENTER or doctor/ physician if you feel unwell.
Specific treatment (see supplemental first aid instructions on this label).
If skin irritation occurs: Get medical advice/ attention.
If eye irritation persists: Get medical advice/ attention.
Take off contaminated clothing and wash before reuse.
Store in a well-ventilated place. Keep container tightly closed.
Dispose of contents/ container to an approved waste disposal plant.
HMIS Classification Health hazard: Chronic Health Hazard: Flammability: Physical hazards: NFPA Rating Health hazard: Reactivity Hazard: Potential Health Effects Inhalation
May be harmful if inhaled. Causes respiratory tract irritation.
Harmful if absorbed through skin. Causes skin irritation.
Ingestion
3. COMPOSITION/INFORMATION ON INGREDIENTS
Levodopa 3-(3,4-Dihydroxyphenyl)-L-alanine L-DOPA
Levodopa 59-92-7
4. FIRST AID MEASURES General advice Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In case of skin contact Wash off with soap and plenty of water. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Sigma - D9628
5. FIRE-FIGHTING MEASURES Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special protective equipment for fire-fighters Wear self contained breathing apparatus for fire fighting if necessary. Hazardous combustion products Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx)
6. ACCIDENTAL RELEASE MEASURES Personal precautions Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. Environmental precautions Do not let product enter drains. Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
7. HANDLING AND STORAGE Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire protection. Conditions for safe storage Keep container tightly closed in a dry and well-ventilated place.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values.
Personal protective equipment Respiratory protection For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Hand protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. Eye protection Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin and body protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Hygiene measures Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Sigma - D9628 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance Safety data
Melting point/range: 276 - 278 °C (529 - 532 °F) - lit.
10. STABILITY AND REACTIVITY Chemical stability Stable under recommended storage conditions. Possibility of hazardous reactions no data available Conditions to avoid Air Light. Materials to avoid Strong oxidizing agents Hazardous decomposition products Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx) Other decomposition products - no data available
11. TOXICOLOGICAL INFORMATION Acute toxicity Oral LD50 LD50 Oral - rat - 1,780 mg/kg Remarks: Behavioral:Excitement. Behavioral:Ataxia. Behavioral:Aggression. Inhalation LC50 Dermal LD50 no data available
Sigma - D9628 Other information on acute toxicity no data available Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitization no data available Germ cell mutagenicity no data available Carcinogenicity
No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH.
No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP.
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA.
Reproductive toxicity Teratogenicity Specific target organ toxicity - single exposure (Globally Harmonized System) Inhalation - May cause respiratory irritation. Specific target organ toxicity - repeated exposure (Globally Harmonized System) no data available Aspiration hazard no data available Potential health effects Inhalation
May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion
Harmful if absorbed through skin. Causes skin irritation.
Signs and Symptoms of Exposure Nausea, Headache, Vomiting Synergistic effects no data available Additional Information RTECS: AY5600000
12. ECOLOGICAL INFORMATION Toxicity Persistence and degradability
Sigma - D9628 Bioaccumulative potential no data available Mobility in soil no data available PBT and vPvB assessment no data available Other adverse effects
13. DISPOSAL CONSIDERATIONS Product Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material. Contaminated packaging Dispose of as unused product.
14. TRANSPORT INFORMATION DOT (US) Not dangerous goods IMDG Not dangerous goods IATA Not dangerous goods
15. REGULATORY INFORMATION OSHA Hazards Target Organ Effect, Harmful by ingestion., Irritant SARA 302 Components SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302. SARA 313 Components SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313. SARA 311/312 Hazards Acute Health Hazard, Chronic Health Hazard Massachusetts Right To Know Components No components are subject to the Massachusetts Right to Know Act. Pennsylvania Right To Know Components New Jersey Right To Know Components California Prop. 65 Components
WARNING! This product contains a chemical known to the State of
California to cause birth defects or other reproductive harm.
16. OTHER INFORMATION
Sigma - D9628 Further information Copyright 2011 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only. The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
Sigma - D9628
Forskning som bedrivs vid enheten Publikationslista 2006-2011 Vetenskapliga artiklar Björling G, Johansson U-B , Andersson G, Schedin U, Markström A, Frostell C. A retrospective survey of outpatients with long-term tracheostomy. Acta Anaesthesiologica Scandinavia, 2006; 50: 399-406. Börjel AK, Yngve A , Sjöström M, Nilsson TK. Novel mutations in the 5’UTR of the FOLR1 g
ARE ENERGY DRINKS HARMFU Think that caffeinated energy drink is a healthy afternoon pick-me-up? Some experts disagree and are urging the US Food and Drug Administration (FDA) to require companies to put health warning labels on their energy-boosting drinks. Apparently, the beverages’ high caffeine content may pose a serious consumer health risk, especially for ki